USD1039677S1 - Pill - Google Patents

Pill Download PDF

Info

Publication number
USD1039677S1
USD1039677S1 US29/826,108 US202229826108F USD1039677S US D1039677 S1 USD1039677 S1 US D1039677S1 US 202229826108 F US202229826108 F US 202229826108F US D1039677 S USD1039677 S US D1039677S
Authority
US
United States
Prior art keywords
pill
view
perspective
another embodiment
ornamental design
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/826,108
Inventor
Martin Asmussen
Mette Høg Gaunø
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority to US29/826,108 priority Critical patent/USD1039677S1/en
Application granted granted Critical
Publication of USD1039677S1 publication Critical patent/USD1039677S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a top perspective view of a pill showing our new design;
FIG. 2 is a bottom perspective view thereof;
FIG. 3 is a front view thereof;
FIG. 4 is a rear view thereof;
FIG. 5 is a left side view thereof;
FIG. 6 is a right side view thereof;
FIG. 7 is a top view thereof;
FIG. 8 is a bottom view thereof;
FIG. 9 is a bottom perspective view of another embodiment thereof, the top perspective, front, rear, left side, right side, and top views being identical to FIG. 1 and FIGS. 3-7 ;
FIG. 10 is a bottom view thereof;
FIG. 11 is a bottom perspective view of another embodiment thereof, the top perspective, front, rear, left side, right side, and top views being identical to FIG. 1 and FIGS. 3-7 ; and,
FIG. 12 is a bottom view thereof.
The broken lines depict portions of the pill which form no part of the claimed design.

Claims (1)

    CLAIM
  1. The ornamental design for a pill, as shown and described.
US29/826,108 2019-03-19 2022-02-09 Pill Active USD1039677S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/826,108 USD1039677S1 (en) 2019-03-19 2022-02-09 Pill

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29/684,226 USD906513S1 (en) 2019-03-19 2019-03-19 Pill
US29/760,683 USD947358S1 (en) 2019-03-19 2020-12-03 Pill
US29/826,108 USD1039677S1 (en) 2019-03-19 2022-02-09 Pill

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US29/760,683 Continuation USD947358S1 (en) 2019-03-19 2020-12-03 Pill

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US29/944,883 Continuation USD1120291S1 (en) 2024-05-30 Pill

Publications (1)

Publication Number Publication Date
USD1039677S1 true USD1039677S1 (en) 2024-08-20

Family

ID=74041278

Family Applications (3)

Application Number Title Priority Date Filing Date
US29/684,226 Active USD906513S1 (en) 2019-03-19 2019-03-19 Pill
US29/760,683 Active USD947358S1 (en) 2019-03-19 2020-12-03 Pill
US29/826,108 Active USD1039677S1 (en) 2019-03-19 2022-02-09 Pill

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US29/684,226 Active USD906513S1 (en) 2019-03-19 2019-03-19 Pill
US29/760,683 Active USD947358S1 (en) 2019-03-19 2020-12-03 Pill

Country Status (1)

Country Link
US (3) USD906513S1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1120291S1 (en) * 2024-05-30 2026-03-24 Novo Nordisk A/S Pill

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD906513S1 (en) * 2019-03-19 2020-12-29 Novo Nordisk A/S Pill
USD983481S1 (en) * 2021-11-10 2023-04-18 Helikon Gida Sanayi Ve Ticaret Limited Sirketi Chewing gum
USD1071139S1 (en) * 2023-03-13 2025-04-15 Kenvue Brands Llc Dosage form

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689585A1 (en) 1994-01-19 1996-01-03 Wissenschaftsförderung Der Deutschen Brauwirtschaft E.V. Beer clarification process by crossflow-microfiltration
USD403396S (en) 1996-11-28 1998-12-29 Astra Aktiebolag Tablet
USD425614S (en) * 1999-04-16 2000-05-23 Merck & Co., Inc. Tablet
USD430285S (en) * 1999-04-16 2000-08-29 Merck & Co., Inc. Tablet
USD431076S (en) * 1999-07-07 2000-09-19 Merck & Co., Inc. Tablet
US6165513A (en) 1997-06-11 2000-12-26 The Procter & Gamble Co. Film-coated tablet for improved upper gastrointestinal tract safety
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet
USD475451S1 (en) 2002-09-09 2003-06-03 Access Business Group International Llc Vitamin tablet
USD535021S1 (en) 2005-04-22 2007-01-09 Wm. Wrigley Jr. Company Elliptical tablet
USD564086S1 (en) 2005-05-30 2008-03-11 Nycomed Pharma A/S Tablet
USD636865S1 (en) 2010-08-25 2011-04-26 KVK-Tech, Inc. Pharmaceutical tablet
USD671636S1 (en) 2010-04-23 2012-11-27 Daiichi Sankyo Company, Limited Pharmaceutical tablet
USD735315S1 (en) 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD754841S1 (en) 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD787043S1 (en) 2015-06-23 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD787042S1 (en) 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD813372S1 (en) 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835257S1 (en) 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD906513S1 (en) 2019-03-19 2020-12-29 Novo Nordisk A/S Pill
USD907760S1 (en) 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5769889A (en) 1996-09-05 1998-06-23 Kelman; Charles D. High myopia anterior chamber lens with anti-glare mask
JP5310424B2 (en) 2009-09-14 2013-10-09 株式会社ジェイテクト Flexure meshing gear unit

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN304516482S (en) 2018-02-23
EP0689585A1 (en) 1994-01-19 1996-01-03 Wissenschaftsförderung Der Deutschen Brauwirtschaft E.V. Beer clarification process by crossflow-microfiltration
USD403396S (en) 1996-11-28 1998-12-29 Astra Aktiebolag Tablet
US6165513A (en) 1997-06-11 2000-12-26 The Procter & Gamble Co. Film-coated tablet for improved upper gastrointestinal tract safety
USD425614S (en) * 1999-04-16 2000-05-23 Merck & Co., Inc. Tablet
USD430285S (en) * 1999-04-16 2000-08-29 Merck & Co., Inc. Tablet
USD431076S (en) * 1999-07-07 2000-09-19 Merck & Co., Inc. Tablet
USD434846S (en) * 1999-07-07 2000-12-05 Merck & Co., Inc. Tablet
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet
USD475451S1 (en) 2002-09-09 2003-06-03 Access Business Group International Llc Vitamin tablet
USD535021S1 (en) 2005-04-22 2007-01-09 Wm. Wrigley Jr. Company Elliptical tablet
USD564086S1 (en) 2005-05-30 2008-03-11 Nycomed Pharma A/S Tablet
USD671636S1 (en) 2010-04-23 2012-11-27 Daiichi Sankyo Company, Limited Pharmaceutical tablet
USD636865S1 (en) 2010-08-25 2011-04-26 KVK-Tech, Inc. Pharmaceutical tablet
USD754841S1 (en) 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD735315S1 (en) 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD787042S1 (en) 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD787043S1 (en) 2015-06-23 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD907760S1 (en) 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet
USD813372S1 (en) 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835257S1 (en) 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD835258S1 (en) 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD858741S1 (en) 2017-02-22 2019-09-03 Celgene Corporation Pharmaceutical tablet
USD906513S1 (en) 2019-03-19 2020-12-29 Novo Nordisk A/S Pill

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Ingenioren ("The Engineer"), "Tabletter mod diabetes abner helt ny aera for Novo Nordisk," May 18, 2018, <https://ing.dk/artikel/tabletter-mod-diabetes-aabner-helt-ny-aera-novo-nordisk-212236>, visited on Mar. 3, 2019.
Medwatch, "Novo Nordisk chases competitive edge with new versions of GLP-1 tablet," Sep. 19, 2018, <https://medwatch.dk/secure/Top_picks_in_english/article10874729.ece>.
U.S. Appl. No. 29/760,683, filed Dec. 3, 2020. (Unpublished).

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1120290S1 (en) * 2020-05-13 2026-03-24 Eli Lilly And Company Pharmaceutical tablet
USD1120291S1 (en) * 2024-05-30 2026-03-24 Novo Nordisk A/S Pill

Also Published As

Publication number Publication date
USD906513S1 (en) 2020-12-29
USD947358S1 (en) 2022-03-29

Similar Documents

Publication Publication Date Title
USD1092044S1 (en) Backpack
USD988390S1 (en) Camera
USD927182S1 (en) Case for earphones
USD930910S1 (en) Helmet
USD903316S1 (en) Case for earphones
USD920097S1 (en) Capsule
USD885460S1 (en) Camera
USD898344S1 (en) Pill box
USD929483S1 (en) Camera
USD901780S1 (en) Helmet
USD915767S1 (en) Suitcase
USD953300S1 (en) Earphones
USD925215S1 (en) Case for earphones
USD897343S1 (en) USB-C dock
USD1042140S1 (en) Dispensing bottle
USD958865S1 (en) Camera
USD931544S1 (en) Helmet
USD1022611S1 (en) Cooler
USD917306S1 (en) Watch case
USD941290S1 (en) Computer
USD900113S1 (en) Tablet case
USD902671S1 (en) Mold
USD886195S1 (en) Tag
USD902282S1 (en) Camera
USD1061010S1 (en) Protected wearable

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY